IO Biotech Inc [NASDAQ: IOBT] gained 2.29% or 0.02 points to close at $0.91 with a heavy trading volume of 292161 shares.
The daily chart for IOBT points out that the company has recorded -21.61% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 350.81K shares, IOBT reached to a volume of 292161 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about IO Biotech Inc [IOBT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IOBT shares is $8.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IOBT stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for IO Biotech Inc is set at 0.08 The Price to Book ratio for the last quarter was 0.84, with the Price to Cash per share for the same quarter was set at 1.22.
Trading performance analysis for IOBT stock
IO Biotech Inc [IOBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 21.84. With this latest performance, IOBT shares gained by 30.67% in over the last four-week period, additionally sinking by -21.61% over the last 6 months – not to mention a drop of -38.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IOBT stock in for the last two-week period is set at 56.45, with the RSI for the last a single of trading hit 63.78, and the three-weeks RSI is set at 50.68 for IO Biotech Inc [IOBT]. The present Moving Average for the last 50 days of trading for this stock 0.9804, while it was recorded at 0.8201 for the last single week of trading, and 1.2519 for the last 200 days.
IO Biotech Inc [IOBT]: A deeper dive into fundamental analysis
IO Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.37 and a Current Ratio set at 5.37.
An analysis of Institutional ownership at IO Biotech Inc [IOBT]
There are presently around $76.79%, or 76.97%% of IOBT stock, in the hands of institutional investors. The top three institutional holders of IOBT stocks are: VIVO CAPITAL, LLC with ownership of 6.17 million shares, which is approximately 9.3706%. NOVO HOLDINGS A/S, holding 4.43 million shares of the stock with an approximate value of $$5.18 million in IOBT stocks shares; and NOVO HOLDINGS A/S, currently with $$4.26 million in IOBT stock with ownership which is approximately 5.5251%.
